pharma

By Jonah Comstock 10:22 am July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular. Last week the...
By Aditi Pai 08:20 am March 16, 2015
More collaboration between chief information officers (CIO) and chief marketing officers (CMO) at pharmaceutical companies could lead to more optimized use of digital technology, according to a survey from Accenture. Accenture interviewed 22 CIOs and 24 CMOs from pharmaceutical companies in eight countries that were bringing in at least $5 billion in annual revenues. While 91 percent of CIOs at...
By Jonah Comstock 08:21 am March 4, 2015
At Everyday Health's fourth quarterly earnings call since going public last year, CEO Ben Wolin spoke about the growing importance of mobile to the company's business, as well as some of the other trends that are driving the company. Everyday Health offers consumers an app and web tool to aggregate health information on a variety of topics, including nutrition, diabetes, fitness, digestive health...
By Jonah Comstock 10:30 am February 25, 2015
Paul Ivans As payors and providers advance toward outcomes-based medicine, that shift is affecting pharmaceutical companies as well. As decisions about prescribing shift away from the doctor, who has been the primary recipient of pharma marketing for the past 20 years, to the C-level of integrated delivery networks (IDNs) and accountable care organizations (ACOs), pharma is going to have to...
By Jonah Comstock 08:40 am February 24, 2015
Monique Levy, VP of Research at Manhattan Research Although there's a lot of buzz about wearables and a lot of talk about tablets, the best digital channel to reach patients and consumers is still the smartphone, according to Manhattan Research's Monique Levy. At the ePharma Summit in New York City, Levy shared some data with an assembled crowd of pharma marketers about how patients use mobile...
By Jonah Comstock 06:19 am January 12, 2015
Qualcomm is already one of the biggest investors in digital health, according to Rock Health. Qualcomm and Novartis, which announced a partnership just last week for mobile-enabled clinical trials, will also be banding together to start an investment firm, the companies announced ahead of the JP Morgan Healthcare event this week. Qualcomm Ventures and Novartis will leverage up to $100 million...
By Jonah Comstock 06:29 am October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...
By Jonah Comstock 05:00 am July 28, 2014
Cambridge, Massachusetts-based flexible electronics company MC10 has embarked on its first public partnership with a pharmaceutical company, Belgium-based UCB. Although many of the details remain undisclosed, the companies have announced that UCB will use MC10's BioStamp technology to pursue new therapies for neurological disorders. "They’re going to combine our devices with their work to...
By Jonah Comstock 09:49 am April 30, 2014
A team of researchers has found that, for 23 commonly used drugs, well over three times as many adverse drug reactions were reported on Twitter in a given time period than were reported to the FDA. Of course, the study also notes that the tweeted reports, referred to as "Proto AEs" (adverse events) weren't necessarily as specific or useful as FDA adverse event reports. Over a six-month period,...
By Jonah Comstock 09:01 am April 17, 2014
The Inspiromatic inhaler. Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...